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Abstract
In January 2010 two groups independently published the observation that the depletion of CD8+ cells in SIV-infected
macaques had no detectable impact on the lifespan of productively infected cells. This unexpected observation led the
authors to suggest that CD8+ T cells control SIV viraemia via non-lytic mechanisms. However, a number of alternative
plausible explanations, compatible with a lytic model of CD8+ T cell control, were proposed. This left the field with no
consensus on how to interpret these experiments and no clear indication whether CD8+ T cells operated primarily via a lytic
or a non-lytic mechanism. The aim of this work was to investigate why CD8+ T cells do not appear to reduce the lifespan of
SIV-infected cells in vivo.
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Introduction
One of the most direct and convincing demonstrations of the
importance of CD8+ T cells in controlling SIV infection in vivo is
the observation that, on depleting CD8+ cells, SIV-1 viral load
increases by 0.5–1 log. This observation has been made in both
acute and chronic infection and has been replicated by a number
of groups [1–3].
In 2010 two ground-breaking papers by Klatt et al and Wong et
al, reported that following CD8+ cell depletion, although there
was a robust increase in viral load, there was no increase in the
lifespan of cells productively infected with SIV [4,5]. That is, when
the lifespan of productively infected cells was measured there was
no detectable difference between control macaques with an intact
CD8+ T cell response and CD8+-depleted macaques. This highly
unexpected result forced a re-evaluation of the role of CD8+ T
cells in SIV infection and the authors concluded that CD8+ T cells
controlled viral load (since CD8+ cell depletion lead to an increase
in viral load) but that control was primarily via non-lytic
mechanisms (since CD8+ depletion did not increase the lifespan
of infected cells).
However, it has been argued that the data are not incompatible
with a lytic mechanism of CD8+ T cell control. It has been
hypothesised that (i) ART-treatment may impair CD8+ T cell
killing (ii) CD8+ T cell killing may occur just before the cell would
die anyway [6] (iii) CD8+ T cell killing may occur prior to viral
production [4,7] or (iv) the measurements of lifespan may not be
sufficiently accurate to detect a difference between depleted and
control animals.
The aim of this project was to firstly investigate whether the lack
of an effect of CD8-depletion on lifespan is compatible with CD8+
T cell control of SIV viraemia via a lytic mechanism and then to
establish whether the data best supports a lytic or non-lytic
mechanism of CD8+ T cell control.
Results
The data of Klatt et al [4] was analysed. Briefly, 10 SIVmac239-
infected rhesus macaques were divided into two groups of 5. One
group (‘‘control’’) was treated with antiretroviral therapy (ART)
alone, the other was first depleted of CD8+ lymphocytes by
OKT8F mAb injection and then treated with ART (‘‘depleted’’).
Depletion was performed in both early and late chronic infection
(Methods). The death rate (1/lifespan) of short-lived productively
infected cells was estimated from the rate of viral clearance
following ART [8,9]. Estimated death rates and model fits are
shown in the supplementary information (see Table S1 and Figure
S1 in Text S1).
The analysis was divided into two parts. First, we investigated
whether the similar death rates of productively infected cells in
control and depleted macaques rule out the possibility that CD8+
T cells act predominantly via lysis. Second, we investigated how
well lytic and non-lytic mechanisms explain the longitudinal
dynamics of viral load and CD4 T cell count.
1. Do the data rule out a lytic mechanism of action?
There are a number of explanations that potentially reconcile
the lack of an effect of CD8-depletion on infected cell lifespan with
a major cytolytic role for CD8+ T cells. We investigated each of
these possibilities in turn.
(i) Impairment of CTL function by ART. It has been
observed that protease inhibitors impair CD8+ T cell function
PLoS Computational Biology | www.ploscompbiol.org 1 September 2011 | Volume 7 | Issue 9 | e1002200[10,11]. Whilst this phenomenon has not been reported for the
reverse transcriptase inhibitors used in this study we decided to
assess the impact of ART on CD8+ T cell function as this could
explain the absence of an effect of CD8+ cell depletion on infected
cell lifespan. The frequency of functional SIV-specific CD8+ cells
was quantified by staining for IFNc, TNFa, Il-2 and CD107
following ex vivo stimulation by SIV peptides. The frequency of
IL-2+ and CD107+ cells was reduced following ART (Figure 1)
consistent with [12]. Therefore, one explanation for the similar
lifespan of infected cells in depleted and control animals is that
ART impaired CD8+ T cell lytic function rendering control
animals similar to CD8-depleted animals. To test this hypothesis
we included the frequency of lytic CD8+ cells (quantified by
CD107 expression) in the model and calculated the death rate of
infected cells corrected for reduced CD8+ T cell function i.e. we
estimated what the death rate of short-lived infected cells would
have been in control animals if CD8+ T cell function was not
impaired. Although this correction did increase the death rate of
infected cells in control animals and thus increased the difference
between control and depleted animals we only found a significant
difference between the groups when we assumed all infected cell
death was due to CTL killing (Figure 1). The current estimate of
the fraction of total death rate attributable to CTL-killing is 20–
30% (section iv and [13,14]). We conclude that the negative effect
of ART on CD8+ T cell function is unlikely to explain similar
infected cell death rates in control and depleted macaques.
(ii) CD8+ T cell killing may occur just before the cell
would die anyway or (iii) prior to viral production. Two
groups have suggested that CD8+ T cells may control viral load via
lytic mechanisms but have little impact on infected cell lifespan due
to the infected cell lifecycle. Klenerman et al [6] suggested that if
viral production increased with the duration of cell infectionand the
virus is highly cytopathic then CD8+ T cells may have little impact
on the lifespan of the infected cell (as they kill infected cells shortly
before they would die anyhow) but may have a large impact on viral
load (as reducing the infected cell lifespan even by only a small
amount prevents a large proportion of viral production). Althaus et
al [7] proposed the opposite model: that CD8+ T cells kill infected
cells prior to viral production. They suggested that, prior to de novo
production of viral proteins, infected cells are a target for CD8+ T
cells recognising viral proteins in the infecting particles but that later
in the viral life cycle, when the cell is productively infected, they
evade CD8+ T cell surveillance due to Nef-induced down-
regulation of MHC class I A and B molecules. CD8+ T cells thus
kill infected cells but do not shorten the lifespan of productively
infected cells which is what is quantified during ART treatment.
Both these possibilities are qualitatively consistent with the
observations of Klatt et al, i.e. they could in principle reconcile a
model in which CD8+ T cell exert their anti-viral control by a lytic
mechanism withthe lack of an impact of depletion on the lifespan of
productively infected cells (see Figure S2 in Text S1 and [7]).
However, it was clear that the reconciliation could only be achieved
for a minority of parameter values. In part 2 we investigate whether
these parameter values are consistent with SIV dynamics.
(iv) The measurements of infected cell lifespan are not
accurate enough. One of the simplest explanations for the
similarity in infected cell lifespan between control and CD8-
depleted animals is that CD8+ T cells control viraemia by a purely
lytic mechanism but the estimates of lifespan are not accurate
enough to detect the increase in lifespan following depletion.
There are three steps to testing this explanation:
1- estimate the increase in lifespan that would be expected
following depletion if CD8+ T cells controlled viraemia by
lysis.
2- estimate the errors on the measurements of lifespan of
productively infected cells.
3- test if the experimental design is sufficient to observe the
expected difference in lifespan between depleted and control
animals.
If CD8+ T cells control viraemia by a purely lytic mechanism
and target cell numbers are constant, then the rate of increase of
viral load following CD8+ cell depletion is equal to the rate of lysis
of productively infected cells by CD8+ T cells. We estimate that, in
these 10 macaques, the geometric mean of the rate of increase in
viral load is 0.25d
21 (see Table S2 in Text S1). So the rate of lysis
of productively infected cells by CD8+ T cells is approximately
0.25d
21; this is similar to previous estimates of the rate of CD8+ T
cell killing made using two independent approaches [13,14].
Relaxing the assumption of constant target cells has little impact
on the estimate of the rate of CTL killing (Text S1). Since it was
necessary to start ART soon after CD8+ depletion there are only 3
viral load measurements from which we can estimate the rate of
increase of viral load following CD8+ depletion. This makes
Figure 1. Effect of ART-treatment on CD8+ T cell function. A)
Frequency of CD107+ CD8 T cells. Cells were stimulated ex vivo with
either gag (black), pol (grey) or env (white) peptides and CD107-
expression was measured. B) Death rate of short-lived productively
infected cells corrected for reduced CTL function after ART treatment at
different contribution of CD8+ T cells to total death rate (filled triangles;
mean from left to right: 0.67, 0.72, 0.77, 0.83, 0.94, 1.04, 1.16, 1.32, 1.51,
1.67, 2.77d
21) compared to the death rate of short-lived productively
infected cells in CD8-depleted animals (open dots; offset to the right,
these estimates are independent of f, mean 1.08d
21).
doi:10.1371/journal.pcbi.1002200.g001
Author Summary
Several studies have shown a role for CD8+ T cells in
controlling SIV-infection. However, early last year two
groups independently showed that depletion of CD8+
lymphocytes did not result in a measurable increase in the
lifespan of productively infected cells, suggesting that
direct cell killing may not be the major mechanism of
antiviral activity by CD8+ lymphocytes. We investigated
whether the lack of an effect on lifespan of infected cells
indeed excludes a lytic role for CD8+ cells and whether a
non-lytic effect of CD8+ cells, for instance by preventing
new infections or blocking production of free virions,
better explains the similar death rates of SIV-infected cells
in animals with and without CD8+ lymphocytes. We found
that, even though lytic models of CD8+ cell function are
compatible with the absence of an effect of CD8+ cells on
the lifespan of productively infected cells, the most likely
mechanism of CD8-control in SIV-infection is via a non-lytic
mechanism.
CD8+ T Cells and Lifespan of SIV-Infected Cells
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explored possible sources of error in our estimates but found little
evidence for significant inaccuracy (see Figure S3 in Text S1). Our
estimates are similar to those reported by Wong et al [1]
(geometric mean 0.39 d
21) but lower than the rates implied by
Jin et al (geometric mean 0.8d
21). Differences could be due to
differences in the viral strain and/or depletion protocol and
timing. So, even if all of the increase in viraemia following
depletion is attributable to loss of CD8+ T cell control and all of
this control is exerted via lytic mechanisms, the predicted decrease
in death rate following CD8-depletion is relatively small: about 0.3
per day, and may not be readily detectable.
Next, it is necessary to assess how accurately the lifespan (i.e. 1/
death rate) of productively infected cells can be measured. We
evaluated 4 widely used methods of estimating the errors on the
measurements of infected cell lifespan (Methods). We found that
the optimal method was bootstrapping the cases followed by
trimming of extremes; the method employed in the original
manuscript of Klatt et al (bootstrapping the residuals) tended to
underestimate the error that is, it gave optimistically tight
confidence intervals (see Figure S4 in Text S1).
Figure 2 shows the estimates of the death rates of short-lived
productively infected cells in control and depleted macaques with
errors on the estimates calculated using the optimal method. It can
be seen that the errors are large and consequently, although the
difference in death rates between depleted and control animals is
about zero, our confidence in this difference is poor. To quantify
this confidence we estimated the distribution of the difference in
death rates between depleted and control animals. This yielded a
broad distribution both for early chronic and late chronic infection
(Figure 3). Although the distributions were centred on zero (i.e.
they supported the original conclusion that there was no difference
in the death rates of infected cells in the presence and absence of
CD8+ T cells) they were not incompatible with a substantial
difference in death rates up to and including the death rate if all
viral control is attributable to CTL lysis (0.3 per day). Removing
two animals with particularly large error bars did not change this
result. We conclude that the estimates of productively infected cell
death are not sufficiently accurate to rule out the possibility that all
control of viraemia is via lytic mechanisms.
Even if the measurements of the death rates of productively
infected cells in control and depleted animals are not accurate
enough to detect a significant difference between the two groups
intuitively we might expect to at least see a trend towards higher
death rates in control animals. However, this was not the case (see
Figure S5 in Text S1). This underlines the difficulty to observe
differences between control and depleted animals.
Wong et al [5] also investigated whether their estimates of the
death rate were sufficiently accurate to exclude a lytic role for
CD8+ T cells and, using a different method, they concluded the
opposite to us, i.e. that their experiments were sufficiently
accurate. However, there was a minor numerical discrepancy in
their calculation (Text S1), when we adjusted this we found that
their conclusions were reversed and they could no longer exclude a
lytic role for CD8+ T cells.
To summarize, we show that the lack of an effect of depletion
on the lifespan of infected cells is not sufficient to rule out a lytic
mechanism. A number of different explanations including models
that assume early CTL killing in the eclipse phase; models that
assume late CTL killing just before the cell would die anyhow and
simple lytic models that reflect the inaccuracy of death rate
measurements and thus our inability to detect differences between
control and depleted animals, are all capable of explaining the lack
of an effect of depletion on lifespan of infected cells. In contrast,
impairment of CD8+ T cell function by ART cannot explain the
similar death rates in depleted and control animals. Next we
investigated how well each of the models which work in principle
predict viral load and CD4+ T cell dynamics in SIV infected
macaques.
2. Are the data more consistent with a lytic or non-lytic
mechanism of action?
Having established that the estimated rates of viral clearance
were not incompatible with purely lytic models of CD8+ T cell
control we then investigated whether the dynamics of infection
were more consistent with CD8+ T cells exerting their antiviral
effects via a lytic or a non-lytic mechanism.
We considered four models of lytic control and four models of
non-lytic control. The lytic control models were chosen to describe
the scenarios which (in part 1 above) were found to be qualitatively
consistent with the lack of an effect of depletion on infected cell
Figure 2. Estimated death rate of short-lived productively
infected cells. Error bars represent the 95% confidence interval
calculated using the optimal method (bootstrapping the cases and
trimming the extremes).
doi:10.1371/journal.pcbi.1002200.g002
Figure 3. Distribution of the difference in death rate between
depleted and control animals. A) early chronic infection, B) late
chronic infection. These distributions represent the difference in short-
lived productively infected cell death rates which are supported by the
experimental data; the grey shading is the 2.5% tails. The distributions
are approximately centred on zero i.e. the most likely scenario is that
there is no difference in death rates of infected cells between control
and depleted animals. However, the distributions are broad and large
differences in the death rates, up to and including the differences which
would be expected if all CD8+ T cell control was via a lytic mechanism,
are also supported by the data. The filled symbol and horizontal lines
represent the mean and 95% confidence interval of the difference in
death rates if all CD8+ T cell mediated control was via a lytic mechanism
(mean=0.3d
21). A: mean difference=0.05d
21 95% CI: 20.33d
21 to
0.51d
21 B: mean difference=20.16d
21 95% CI: 20.70d
21 to 0.44 d
21.
doi:10.1371/journal.pcbi.1002200.g003
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model of lytic control ii) an extension of the basic model to include
two populations of productively infected cells iii) a model following
Klenerman et al [6] in which SIV is cytopathic and iv) a model
following Althaus et al [7] in which CD8+ T cell killing is limited
to the early non-productive stage of the viral lifecycle. The 4 non-
lytic control models were: i) a model in which non-lytic factors
reduced new infection events e.g. beta-chemokines [17,18] ii)a n
extension of model i to include two populations of productively
infected cells iii) a model in which non-lytic factors reduce virion
production [19] iv) an extension of model iii to include two
populations of productively infected cells. To assess which of these
models best describes infection dynamics we fitted each model to
the time course of viral load and CD4+ T cell count in each
macaque (an average of 43 time points over 224 days) and
calculated the small sample Akaike’s information criterion (AICC)
of the best fitting parameter combination (Figure 4 and 5, and
Figure S6 and Table S3 in Text S1).
Although the quality of the fits is rather poor, our results show
clear and consistent support for the non-lytic model in which CD8+
T cellsreduceinfection;none of the lytic models receive any support
for most data sets. The best-fitting non-lytic model (non-lytic model
ii, in which non-lytic factors reduced new infection events and there
are two populations of productively infected cells) was compared
with each of the lytic models in turn. In every case the non-lytic
model provided a significantly better fit (lytic model i higher AICc
6/7 cases P=0.043, mean difference in AICc=15; lytic model ii
higher AICc 6/7 cases P=0.028, mean difference in AICc=26;
lytic model iii higher AICc 7/7 cases P=0.018, mean difference in
AICc=40; lytic model iv higher AICc 7/7 cases P=0.018, mean
difference in AICc=39. All P values 2 tailed paired Mann-
Whitney). Furthermore the non-lytic model in which infection was
reduced performed consistently better than the non-lytic model in
which virion production was reduced though the differences in
performance were not as large as for the comparison between lytic
and non-lytic models (non-lytic model in which virion production
was reduced (iv) had a higher AICc in 7/7 cases compared to the
similar non-lyticmodelii;P=0.018,2 tailedpairedMann-Whitney,
mean difference in the AICc=10).
The reason why the lytic models fail can be seen from studying
the equations. In the lytic models the rate of post-ART decline in
viral load is determined by infected cell death due to viral toxicity
and CD8+ T cell killing. Under the CD8 depletion regime post-
ART decline in viral load is solely determined by infected cell
death due to viral toxicity. Thus, to predict the similar post-ART
decline under the two treatment-regimes lytic models need to
attribute a small role to CD8+ cells. This small role of CD8+ T
cells is poorly compatible with the increase in viral load following
CD8 depletion in the absence of ART. Therefore, lytic models
cannot accurately fit both post-ART decline and the increase in
viral load upon depletion whereas non-lytic models can.
Consequently models with a non-lytic component are likely to
consistently outperform similar models with a lytic component.
We conclude that although self-consistent hypotheses can be
constructed in which CD8+ T cells exert their antiviral effects by
lysis without a detectable impact on infected cell lifespan, these
models are poorly predictive and a non-lytic model provides a
better explanation of the viral load and CD4+ T cell dynamics.
Discussion
SIV-infection of rhesus macaques is one of the best and most
widely used animal models of HIV-1 infection. Indeed, the
observation that CD8+ cell depletion in rhesus macaques causes
an increase in viral load is frequently cited as strong evidence that
CD8+ T cells control infection in HIV-1-infected humans. The
finding that CD8+ T cell depletion has no discernable impact on
infected cell lifespan in SIV-infected macaques is reminiscent of
earlier observations in HIV-1-infected humans in which there was
no relationship between infected cell lifespan and disease stage [6].
That is, in individuals with a high CD4+ T cell count and,
presumably, a relatively intact CD8+ T cell response the lifespan of
infected cells was very similar to individuals with a CD4 count
Figure 4. Experimental data and model fits. Experimental viral
load and percentage CD4+ T cells (filled dots on left column and right
column respectively) and the best fitting non-lytic model (non-lytic
model ii; solid lines) and the best-fitting lytic model (lytic model i;
dashed lines). Number of parameters: 10 and 8 respectively. Model
selection was based in the AICc, which is adjusted for differences in
number of parameters. This figure shows representative data and fits,
the full set can be found in Figure S6 in Text S1. Please note that for
animals in Group B data for CD4+ and CD8+ T cells was only available
from 45 days after infection, hence viral load data before this time point
have not been fitted.
doi:10.1371/journal.pcbi.1002200.g004
Figure 5. Comparison of lytic and non-lyic model fits. The AICc of
the model minus the AICs of the best fitting model for that animal is
shown. A large difference represents a poor fit. Overall the model in
which CD8+ T cells operate via a non-lytic mechanism which reduces
infection offers the best fit in 6 out of 7 cases, a lytic model only offers
the best fit in 1/7 cases. The 4 lytic models are i) the basic model ii) an
extension of the basic model to include two populations of
productively infected cells iii) a model following Klenerman et al in
which SIV is cytopathic and iv) a model following Althaus et al in which
CD8+ T cell killing is limited to the early non-productive stage of the
viral lifecycle. The 4 non-lytic control models were: i) a model in which
non-lytic factors reduced new infection events ii) an extension of model
i to include two populations of productively infected cells iii) a model in
which non-lytic factors reduce virion production iv) an extension of
model iii to include two populations of productively infected cells.
doi:10.1371/journal.pcbi.1002200.g005
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importance and generality of the work of Klatt et al and Wong et al.
We investigated a number of hypotheses to try and reconcile a
major lytic role for CD8+ T cells with the observation that
depletion of CD8+ T cells had little impact on the lifespan of
infected cells. We found evidence that ART impairs CD8+ T cell
function and allowing for this impairment increased the difference
in lifespan between control and depleted animals but the
difference remained small. Following Klenerman et al [6] and
Althaus et al [7] we also investigated models in which CD8+ T cell
killing occurred just prior to when a cell would die anyhow or
prior to viral production. These models were qualitatively
consistent but only for relatively narrow parameter ranges and
required further assumptions (namely that SIV is highly cytopathic
or that infected cells are most vulnerable to CD8+ T cell killing
prior to viral production, respectively). Unexpectedly, the simplest
hypothesis: that the measurements of lifespan were not accurate
enough to detect the difference between control and depleted
animals did offer a plausible explanation.
Depletion of CD8+ T cells results in a large increase in viral load
so intuitively we expect that this implies that CD8+ T cells rapidly
kill infected cells. If lysis is so rapid, it should clearly manifest as an
increase in infected cell lifespan in the absence of CD8+ T cells.
However, the large increase in viral load following depletion occurs
over several days and, even if it is assumed to be due entirely to the
removal of lytic CD8+ T cells, analysis shows that this only implies a
rate of CD8+ T cell killing of 0.3 per day. That is, the rise in
viraemia following CD8+ T cell depletion, indicates that CD8+ T
cells are responsible for about 30% of productively infected cell
death [20]. It is therefore not surprising that it is difficult to detect
evidence for this relatively small contribution to cell death even in
the extreme case of CD8-depleted macaques let alone in humans at
different stages of infection.
Next we investigated which mechanism provides the best
explanation of SIV dynamics in acute and chronic infection. This
analysis found strong support for non-lytic mechanisms of CD8+ T
cell-mediated control of SIV infection, in particular via blocking of
infection.Themodelsweused werefullymechanistic,lowparameter
models which were constrained by CD8+ T cell data and were
required to fit viral load and CD4+ T cell count data simultaneously
over a wide dynamic range. Consequently the divergence between
observation and prediction (particularly for CD4+ T cell counts) was
rather large. Clearly, none of the models used represents the true
model of SIV dynamics. However, the use of the AIC enables us to
select the model which contains most information of the true model,
i.e. is closest to reality [21]. Furthermore, the improved performance
of the non-lytic models compared to the lytic models can be
understood intuitively and is likely to be a general feature of
comparisons between lytic and non-lytic models.
We conclude that on their own, the lifespan estimates of Klatt
and Wong cannot exclude the possibility that CD8+ T cell exert
their antiviral effects via cytolysis. However, in conjunction with
the failure of lytic models to compete with non-lytic models in
predicting the time course of infection, the evidence favours a
picture in which CD8+ T cells control infection via the production
of non-lytic factors that reduce infection.
Methods
Ethics statement
This study was carried out in strict accordance with the
Association for Assessment and Accreditation of Laboratory
Animal Care guidelines and the protocol was approved by the
Emory University IACUC (#062-2007Y).
Experiment design
Ten SIVmac239-infected rhesus macaques were divided into two
equal groups. Animals in group A were CD8+ lymphocyte
depleted during early chronic phase. Animals in group B were
CD8+ lymphocyte depleted during the late chronic phase.
Antiretroviral therapy (ART) was given to all animals in both
stages. Animals were given OKT8F (CD8-depleting mAb) for 3
consecutive days (Group A, days 58–60 after infection; Group B,
days 177–179). ART (PMPA and FTC) was given for 28
consecutive days during both early and late chronic infection
(starting at d63 and d168 for group A, and d63 and d182 for group
B). These studies were approved by the Emory University and
University of Pennsylvania Institutional Animal Care and Use
Committees. Further details are provided in [4].
Viral load
Plasma viraemia was quantified by real-time reverse-transcrip-
tase PCR.
SIV-specific T cell responses
SIV-specific T cell responses were measured by intracellular
cytokine staining for interferon-c, tumour necrosis factor-a, and
Interleukin-2, as well as the degranulation marker CD107a, in
response to pools of overlapping 15-mer peptides which spanned
SIVmac239 gag, pol and env proteins [4].
Estimating the death rate of productively infected cells
The death rate (1/lifespan) of productively infected cells was
estimated by fitting Eq.1 to viral load after initiation of ART
[4,22].
Vt ðÞ ~Ae{mTtzBe{mMt ð1Þ
where A (B) is the contribution of short-lived (long-lived)
productively infected cells respectively to viral load at time zero,
mT (mM) is the death rate of short-lived (long-lived) productively
infected cells (d
21) respectively.
Basic model of HIV infection: lytic CD8+ T cells
The lytic model describes uninfected target cells (T), produc-
tively infected cells (T
*) and free virus (V). Throughout, a dot
denotes differentiation with respect to time.
T
.
~l{bTV{dTT ð2Þ
T 
.
~bTV{dIT {kET  ð3Þ
V
.
~pT {cV ð4Þ
Where l is inflow of uninfected CD4+ cells (cells.d
21), b is
infection rate, dT and dI death rate of uninfected and infected
CD4+ cells respectively, k is CTL killing rate of infected CD4+
cells, p is production rate of free virions and c clearance rate of free
virions (all d
21) The fraction of CD8
+ T cells, E, is entered as an
empirical function obtained by linear interpolation between data
points. With the exception of a few points, CD8+ and CD4+ T cell
measurements were available whenever viral load measurements
were made.
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infected cells, T* and M*, with different death rates was also
considered. This model is similar to the basic lytic model (Eq. 2 to
Eq. 4) but Eq. 2 and Eq. 3 are duplicated to describe, M*, the
second population of infected cells. In Eq. 4 a term representing
the production of virions by this population, pM*, is added. We
assume that in vivo CTL killing follows the laws of mass action.
The law of mass action has been shown to hold over a wide range
of effector and target cell frequencies including the cell frequencies
found in our experiments [23–26].
Expected decrease in infected cell death rate after CD8+
T cell depletion
We estimated the decrease in infected cell death rate consistent
with the increase in viral load following CD8+ T cell depletion if
CD8+ T cells operate via a purely lytic mechanism. We used the
basic lytic model (Eq. 2 to Eq. 4) and, assuming constant
uninfected target cells T, constant CD8+ T cell killing D prior to
depletion, and a quasi-steady state between infected target cells
and viral load we wrote Eq. 3 as:
V
.
~ b{dI{D ðÞ V ð5Þ
Where b= bpT/c and D=kE. Prior to depletion dV/dt=0, so
D=b-dI; after depletion D=0 and the change in viral load was
described by:
V
.
~ b{dI ðÞ V ð6Þ
If the increase in viral load following CD8-depletion was solely due
to the increase in lifespan of infected cells due to prevention of
CD8 killing, then the estimate of slope (b- dI) gives an estimate of
D. Alternative models including a model with target cell limitation
and a model with an eclipse phase were also considered (Text S1).
Comparing different methods of quantifying the error on
death rate estimates
There are 4 methods that are widely used to estimate errors on
parameter estimates in least-squares regression: the asymptotic
covariance matrix method, bootstrapping the cases, bootstrapping
the cases followed by trimming of extremes and bootstrapping the
fit residuals [27–29]. No single method is optimal for all systems;
the choice of method depends both on the model being fitted and
the distribution of data. To assess the best approach for estimating
the error on the death rate of short-lived productively infected cells
in SIV-infected macaques we generated data in silico using the
equation for viral decline after initiation of ART (Eq. 1), added
random noise, fitted the model to the in silico ‘‘data’’ and then
compared the accuracy of the 95% confidence intervals generated
using the four methods. Further details are provided in Text S1.
Distribution of difference in death rate between depleted
and control animals
The distribution of bootstrap sample estimators approximates
the distribution of the parameter estimator [27] so we constructed
the distribution of the death rate estimates in depleted and control
animals by fitting Eq. 1 to the viral load data in the 10 macaques
following initiation of ART and calculated 5000 trimmed
bootstrap estimates of the death rate for each animal. From these
distributions we sampled, with replacement, a death rate for each
animal and calculated the mean for the five animals in the control
and depleted group and then the difference in the mean between
the two groups. We repeated this 1000 times.
Effect of CD8+ T cell impairment following ART treatment
To investigate if impaired CD8+ T cell function after ART-
treatment, represented by reduced CD107-expression, can explain
the similar death rate estimates found in CD8-depleted and
control animals we explicitly included CD107-expression into the
lytic model with two populations of infected cells (T* and M*).
During ART treatment, infection rate b=0, so the model reduces
to:
T
.
 ~{(1{f)dIT   {f
E(t)
E0
dIT  ð 7Þ
M
.
 ~{ 1{f ðÞ dSM   {f
E(t)
E0
dSM  ð 8Þ
V
.
~pTT   zpMM   {cV ð9Þ
Where dI and dS are the death rates of the T
* and M
* population
and pT and pM are production rates of free virions by the T
* and
M
* population respectively (all in d
21). Fraction f is the proportion
of infected cell death attributable to CD8
+ T cell killing; (1-f) is the
proportion attributable to all other factors. Impaired CD8+ T cell
function was represented by the fraction of CD107+ CD8+ T cells,
E(t), relative to the pre-ART fraction of CD107+ CD8+ T cells,
E0. E(t) was obtained by linear interpolation between data points.
Resulting death rate estimates in control animals (i.e. corrected for
CD8+ T cell impairment) were compared with death rates
estimated in depleted animals using a Mann-Whitney test for
different values of f.
Alternative lytic models: assuming late virion production
and late killing of infected cells
It has been suggested [6] that infected cells initially produce few
virions while the bulk of virions are produced just before the cells
dies. This was represented by 2 populations of SIV-infected cells:
population L* consists of recently infected cells that do not
produce virions and die at a negligible rate; population A*
represents productively infected cells. The population of uninfect-
ed CD4+ T cells was described by Eq. 2.
L 
.
~bTV{tL {dIL  ð10Þ
A 
.
~tL {dAA {kEA  ð11Þ
V
.
~pA {cV ð12Þ
Where t is transition rate from the L
* to the A
* population and dI
and dA are the death rates of the L
* to the A
* population (all d
21).
Alternative lytic models: assuming CTL killing prior to
viral production
This is based on [7] and represented by two populations of SIV-
infected cells: population I
* consists of recently infected cells which
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*
consists of productively infected cells that evade CTL-killing
through down-regulation of MHC-I molecules. Uninfected CD4+
T cells were described by Eq. 2.
I 
.
~bTV{cI {dII {kEI  ð13Þ
P 
.
~cI {dPP  ð14Þ
V
.
~pP {cV ð15Þ
Where c is the transition rate from the I
* to the P
* population and
dP is the death rate of the P
* population (both d
21).
Non-lytic models of HIV infection
The non-lytic models share the basic description of T, T* and V
dynamics (Eq. 2 to Eq. 4). However, in the non-lytic models CD8
+
T cells do not kill infected cells (k=0) but decrease infection rate b
or virion production rate p by a fraction u:
u~1= 1zgEt ðÞ ðÞ ð16Þ
Model fitting
The four different lytic and non-lytic models were fitted to data
of virus load and total CD4
+ T cell population, scaled to obtain
equal mean. E(t) was obtained by linear interpolation of
experimental data. ART-treatment was simulated by setting
infection rate b=0. To fit the models to the data we used the
pseudorandom algorithm in the modFit-function of the FME-
package in R [30].
Model selection
The small sample (second-order) bias adjusted Akaike Informa-
tion Criterion (AICc) [21,31] was used to compare the fit of the
models. The model with the lowest AICc is considered to describe
the experimental data best. As a rule of thumb we assumed
considerable support for models with an AICc within two of the
lowest; if models differ by three to seven AICc units from the
minimum AICc there is some support for the model with the
higher AICc while a difference larger than 10 suggests that the
model is very unlikely [21].
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